Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Octalfa

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 13
Rounds per year 1.47
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 7
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Pharmaceutical
  • Wellness
Summary

Octalfa appeared to be the VC, which was created in 2007. The main department of described VC is located in the u00c9cully. The venture was found in Europe in France.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Octalfa, startups are often financed by Sham Innovation Santu00e9, Pertinence Invest, KREAXI. The meaningful sponsors for the fund in investment in the same round are Sham Innovation Santu00e9, Rhone-Alpes Creation, KREAXI. In the next rounds fund is usually obtained by Sham Innovation Santu00e9, Bpifrance, Sofimac Partners.

The top activity for fund was in 2010. The increased amount of exits for fund were in 2019. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. This Octalfa works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

We also calculated 2 valuable employees in our database.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Orega Biotech, Glycode, NightSwapping. The fund has specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Octalfa:
Typical Co-investors
Octalfa is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Octalfa:

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arkea Capital Investissement France, Ile-de-France, Paris
BnkToTheFuture China, Hong Kong, Hong Kong Island
Bravo Equity Partners -
Bridgewest Group California, San Diego, United States
C15 Ventures China, Hong Kong, Hong Kong Island
Gemcorp England, London, United Kingdom
Gen Z Ventures -
GETTYLAB California, San Francisco, United States
Goldrock Media LLC New York, New York, United States
GU Equity Partners -
Hefei Yijun Chuangye Touzi Guanli Youxian Gongsi Anhui, China, Hefei
Human Longevity and Performance Impact Venture Fund -
ICP England, London, United Kingdom
Tanium Kirkland, United States, Washington
UBS O'Connor Chicago, Illinois, United States
Xinghe Investment China, Guangdong, Tianjin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NightSwapping

Collaborative Consumption
Mobile
Tourism
Travel
$2M10 Sep 2014 Lyon, Auvergne-Rhône-Alpes, France

Mathym

Dental
Health Care
Medical
$708K30 Jun 2014 France, Auvergne-Rhône-Alpes, France

e(ye)BRAIN

Biotechnology
Medical
Medical Device
$3M09 Oct 2012 France, Ile-de-France, France

Orega Biotech

Biotechnology
Health Care
Market Research
Medical
Therapeutics
$3M22 Nov 2010 France, Auvergne-Rhône-Alpes, France

Docea Power

Electronic Design Automation (EDA)
Electronics
Software
$1M02 Jun 2010 France, Auvergne-Rhône-Alpes, France

Glycode

Biopharma
Biotechnology
Medical Device
$3M18 Jan 2010 France, New Aquitaine, France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Octalfa?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 22
Average round size 2M
Rounds per year 1.47
Peak activity year 2012
Lead investments 3
Follow on index 0.41
Exits 7
Group Appearance index 0.73

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

NightSwapping

Collaborative Consumption
Mobile
Tourism
Travel
$2M10 Sep 2014 Lyon, Auvergne-Rhône-Alpes, France

Mathym

Dental
Health Care
Medical
$708K30 Jun 2014 France, Auvergne-Rhône-Alpes, France

e(ye)BRAIN

Biotechnology
Medical
Medical Device
$3M09 Oct 2012 France, Ile-de-France, France

Orega Biotech

Biotechnology
Health Care
Market Research
Medical
Therapeutics
$3M22 Nov 2010 France, Auvergne-Rhône-Alpes, France

Docea Power

Electronic Design Automation (EDA)
Electronics
Software
$1M02 Jun 2010 France, Auvergne-Rhône-Alpes, France

Glycode

Biopharma
Biotechnology
Medical Device
$3M18 Jan 2010 France, New Aquitaine, France
Crunchbase icon

Content report

The following text will be sent to our editors: